← Back to Search

Behavioral Intervention

Elissa's EE Song for Breast Cancer

N/A
Waitlist Available
Led By Jeanine Guidry, PhD
Research Sponsored by Virginia Commonwealth University
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Saudi Arabian
female
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 1 day
Awards & highlights

Study Summary

This clinical trial aims to test if Elissa's Entertainment-Education (EE) song can influence Saudi females' intention to perform breast cancer early screening via mammogram.

Eligible Conditions
  • Breast Cancer
  • Behavior

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check β€œYes” for the criteria below

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~1 day
This trial's timeline: 3 weeks for screening, Varies for treatment, and 1 day for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Measure the role of issue involvement in predicting intention to perform breast cancer early screening via mammogram among Saudi females after exposure to EE message.
Secondary outcome measures
Compare the differences between EE viewers and non EE viewers in terms of issue involvement
Compare the differences between EE viewers and none EE viewers in terms of attitude.
Compare the differences between EE viewers and none EE viewers in terms of perceived behavioral control.
+4 more

Trial Design

3Treatment groups
Experimental Treatment
Active Control
Group I: Elissa's EE SongExperimental Treatment1 Intervention
Participants will have to click on the watch button to start the YouTube video as it is without manipulation. Right after exposure, the first and second arms will be asked if they have seen either of the presented materials before.
Group II: Standard of CareActive Control1 Intervention
Participants will be assigned to read general infographic messages adopted from the Saudi Ministry of Health (MOH) in the breast cancer early screening context in Arabic/English. Right after exposure, the first and second arms will be asked if they have seen either of the presented materials before.
Group III: Control GroupActive Control1 Intervention
The third arm of this trial is the control group who will not be exposed to any preventative messages.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
You-Tube Video: Elissa's EE song
2022
N/A
~240

Find a Location

Who is running the clinical trial?

Virginia Commonwealth UniversityLead Sponsor
691 Previous Clinical Trials
22,884,592 Total Patients Enrolled
18 Trials studying Breast Cancer
2,204 Patients Enrolled for Breast Cancer
Jeanine Guidry, PhDPrincipal InvestigatorVirginia Commonwealth University

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
~78 spots leftby Mar 2025